CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
No abstract available